# NightHawk Biosciences Inc. (NHWK)

Source: https://www.quantisnow.com/company/NHWK
Generated: 2026-11-15T15:20:47.881Z

- Ticker: NHWK
- Exchange: AMEX
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2022

## Latest NHWK news and filings

- 2024-03-19 12:30 UTC [Scorpius Holdings Awarded Contract in Excess of $1 Million with NIH-Funded Researcher at a Major University](https://www.quantisnow.com/insight/scorpius-holdings-awarded-contract-in-excess-of-1-million-with-5353356)
- 2024-03-14 12:30 UTC [Scorpius Holdings Accepted as a Member of the US Government's BioMaP-Consortium](https://www.quantisnow.com/insight/scorpius-holdings-accepted-as-a-member-of-the-us-governments-5343542)
- 2024-03-12 21:00 UTC [Public Offering] [Scorpius Holdings, Inc. Announces Closing of Public Offering](https://www.quantisnow.com/insight/scorpius-holdings-inc-announces-closing-of-public-offering-5338587)
- 2024-03-08 05:20 UTC [Public Offering] [Scorpius Holdings, Inc. Announces Pricing of Public Offering](https://www.quantisnow.com/insight/scorpius-holdings-inc-announces-pricing-of-public-offering-5328640)
- 2024-03-07 21:18 UTC [Public Offering] [Scorpius Holdings, Inc. Announces Proposed Public Offering of Common Stock](https://www.quantisnow.com/insight/scorpius-holdings-inc-announces-proposed-public-offering-of-common-stock-5327128)
- 2024-03-07 13:30 UTC [Scorpius Holdings Estimates Greater than 375% Sequential Increase in Revenue for the Fourth Quarter of 2023 Compared to the Third Quarter of 2023](https://www.quantisnow.com/insight/scorpius-holdings-estimates-greater-than-375-sequential-increase-in-revenue-5325492)
- 2024-02-06 14:34 UTC [SEC Form 8-K] [NightHawk Biosciences Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/nighthawk-biosciences-inc-filed-sec-form-8-k-amendments-to-articles-5232729)
- 2024-02-06 13:18 UTC [Market Chatter] [NightHawk Biosciences Completes Name Change To Scorpius Holdings; Trading To Commence Under "SCPX" Effective At The Market Open Today](https://www.quantisnow.com/insight/nighthawk-biosciences-completes-name-change-to-scorpius-holdings-trading-to-5232367)
- 2024-02-06 13:00 UTC [NightHawk Biosciences Completes Name Change to Scorpius Holdings; Trading to Commence Under "SCPX" Effective at the Market Open Today](https://www.quantisnow.com/insight/nighthawk-biosciences-completes-name-change-to-scorpius-holdings-trading-to-5232255)
- 2024-02-01 13:00 UTC [NightHawk's Scorpius BioManufacturing Subsidiary Announces the Promotion of Joe Payne to President and Chief Operating Officer](https://www.quantisnow.com/insight/nighthawks-scorpius-biomanufacturing-subsidiary-announces-the-promotion-of-joe-payne-5222216)
- 2024-01-30 13:27 UTC [Market Chatter] [NightHawk Receives Proceeds Of $3.25M In Connection With Sale Of Non-Core Intellectual Property And Issuance Of A Low Interest Bearing Note](https://www.quantisnow.com/insight/nighthawk-receives-proceeds-of-325m-in-connection-with-sale-of-5215986)
- 2024-01-30 13:00 UTC [SEC Form 8-K] [NightHawk Biosciences Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/nighthawk-biosciences-inc-filed-sec-form-8-k-entry-into-a-5215888)
- 2024-01-30 13:00 UTC [NightHawk Receives Proceeds of $3.25 Million in Connection with Sale of Non-Core Intellectual Property and Issuance of a Low Interest Bearing Note](https://www.quantisnow.com/insight/nighthawk-receives-proceeds-of-325-million-in-connection-with-sale-5215831)
- 2024-01-26 21:30 UTC [SEC Form 8-K] [NightHawk Biosciences Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/nighthawk-biosciences-inc-filed-sec-form-8-k-other-events-financial-5211410)
- 2024-01-25 13:31 UTC [Market Chatter] [NightHawk's Scorpius BioManufacturing Subsidiary Awarded A Multimillion- Dollar Contract With A Biotech Company To Support Its Phase 2 Clinical Program](https://www.quantisnow.com/insight/nighthawks-scorpius-biomanufacturing-subsidiary-awarded-a-multimillion--dollar-contract-with-5206667)
- 2024-01-25 13:30 UTC [NightHawk's Scorpius BioManufacturing Subsidiary Awarded Multimillion- Dollar Contract with a Publicly Traded Biotech Company to Support its Phase 2 Clinical Program](https://www.quantisnow.com/insight/nighthawks-scorpius-biomanufacturing-subsidiary-awarded-multimillion--dollar-contract-with-a-5206635)
- 2024-01-22 13:00 UTC [SEC Form 8-K] [NightHawk Biosciences Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/nighthawk-biosciences-inc-filed-sec-form-8-k-other-events-financial-5197540)
- 2024-01-19 17:31 UTC [Market Insight] [12 Health Care Stocks Moving In Friday's Intraday Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-fridays-intraday-session-5195905)
- 2024-01-16 13:30 UTC [SEC Form 8-K] [NightHawk Biosciences Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/nighthawk-biosciences-inc-filed-sec-form-8-k-regulation-fd-disclosure-5187653)
- 2024-01-16 13:30 UTC [NightHawk's Scorpius BioManufacturing Subsidiary Commences Work on Preclinical Program for New Client](https://www.quantisnow.com/insight/nighthawks-scorpius-biomanufacturing-subsidiary-commences-work-on-preclinical-program-for-5187627)
- 2024-01-11 21:59 UTC [SEC Form 8-K] [NightHawk Biosciences Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/nighthawk-biosciences-inc-filed-sec-form-8-k-other-events-financial-5184504)
- 2024-01-08 13:55 UTC [Market Chatter] [NightHawk Biosciences Announces Planned Name Change To Scorpius Holdings, Reflecting Successful Transition To A Large Molecule Biomanufacturing CDMO; In Connection With The Name Change, The Company's Ticker Will Change To "SCPX"](https://www.quantisnow.com/insight/nighthawk-biosciences-announces-planned-name-change-to-scorpius-holdings-reflecting-5175378)
- 2024-01-08 13:30 UTC [SEC Form 8-K] [NightHawk Biosciences Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/nighthawk-biosciences-inc-filed-sec-form-8-k-regulation-fd-disclosure-5175234)
- 2024-01-08 13:30 UTC [NightHawk Biosciences Announces Planned Name Change to Scorpius Holdings, Reflecting Successful Transition to a Large Molecule Biomanufacturing CDMO](https://www.quantisnow.com/insight/nighthawk-biosciences-announces-planned-name-change-to-scorpius-holdings-reflecting-5175202)
- 2024-01-03 13:30 UTC [NightHawk Biosciences Commences Work on Multi-Million-Dollar Development and Manufacturing Agreement For a Leading National University](https://www.quantisnow.com/insight/nighthawk-biosciences-commences-work-on-multi-million-dollar-development-and-manufacturing-agreement-5163175)
- 2023-12-27 21:57 UTC [SEC Form 8-K] [NightHawk Biosciences Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits](https://www.quantisnow.com/insight/nighthawk-biosciences-inc-filed-sec-form-8-k-completion-of-acquisition-5156436)
- 2023-12-21 13:47 UTC [Market Chatter] [NightHawk Biosciences Announces Completion Of Demonstration Run For A Top-Tier NIH And DTRA Funded Research University](https://www.quantisnow.com/insight/nighthawk-biosciences-announces-completion-of-demonstration-run-for-a-top-tier-5150324)
- 2023-12-21 13:30 UTC [NightHawk Biosciences Announces Completion of Demonstration Run for a Top-Tier NIH and DTRA Funded Research University](https://www.quantisnow.com/insight/nighthawk-biosciences-announces-completion-of-demonstration-run-for-a-top-tier-5150272)
- 2023-12-19 22:01 UTC [Market Chatter] [Nighthawk Biosciences Files For Mixed Shelf Of Up To $200M; At Market Offering Prospectus Covering Offer Of Up To $4.04M Of Common Stock That May Be Issued And Sold From Time To Time](https://www.quantisnow.com/insight/nighthawk-biosciences-files-for-mixed-shelf-of-up-to-200m-5147002)
- 2023-12-19 21:47 UTC [SEC Form S-3] [SEC Form S-3 filed by NightHawk Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-s-3-filed-by-nighthawk-biosciences-inc-5146881)
- 2023-12-19 21:16 UTC [SEC Form 424B5] [SEC Form 424B5 filed by NightHawk Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-nighthawk-biosciences-inc-5146503)
- 2023-12-19 21:05 UTC [SEC Form 8-K] [NightHawk Biosciences Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/nighthawk-biosciences-inc-filed-sec-form-8-k-other-events-financial-5146342)
- 2023-12-18 18:05 UTC [Market Insight] [Why Lantheus Holdings Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Monday's Mid-Day Session](https://www.quantisnow.com/insight/why-lantheus-holdings-shares-are-trading-lower-by-over-22-5143116)
- 2023-12-18 13:40 UTC [Market Chatter] [NightHawk Biosciences Announces Major Milestone With Completion Of Manufacturing Run For A Premier U.S.-Based Biopharmaceutical Company; Advances Multi-million Dollar Biomanufacturing Contract Awarded Earlier This Year](https://www.quantisnow.com/insight/nighthawk-biosciences-announces-major-milestone-with-completion-of-manufacturing-run-5142432)
- 2023-12-18 13:30 UTC [NightHawk Biosciences Announces Major Milestone with Completion of Manufacturing Run for a Premier U.S.-Based Biopharmaceutical Company](https://www.quantisnow.com/insight/nighthawk-biosciences-announces-major-milestone-with-completion-of-manufacturing-run-5142373)
- 2023-12-12 21:42 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by NightHawk Biosciences Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-nighthawk-biosciences-inc-amendment-5133354)
- 2023-12-12 21:31 UTC [Market Insight] [12 Health Care Stocks Moving In Tuesday's After-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-tuesdays-after-market-session-5133255)
- 2023-12-12 21:03 UTC [SEC Form 8-K] [NightHawk Biosciences Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Leadership Update, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/nighthawk-biosciences-inc-filed-sec-form-8-k-entry-into-a-5132916)
- 2023-12-12 13:36 UTC [Market Chatter] [NightHawk Biosciences Announces Announces Shift To Pure-Play Large Molecule Biomanufacturing CDMO And Will Divest Its Elusys And Related Assets](https://www.quantisnow.com/insight/nighthawk-biosciences-announces-announces-shift-to-pure-play-large-molecule-biomanufacturing-5132007)
- 2023-12-12 13:30 UTC [NightHawk Biosciences Announces Strategic Shift into a Pure-Play Large Molecule Biomanufacturing CDMO to Capitalize on Rapid Growth in Sales Pipeline along with Divestiture of Non-Core Assets](https://www.quantisnow.com/insight/nighthawk-biosciences-announces-strategic-shift-into-a-pure-play-large-molecule-5131954)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/NHWK
- Earnings history: https://www.quantisnow.com/earnings/NHWK
- Dividend history: https://www.quantisnow.com/dividends/NHWK
- Insider transactions: https://www.quantisnow.com/insiders/NHWK
- Options chain: https://www.quantisnow.com/options/NHWK
- SEC 8-K filings only: https://www.quantisnow.com/company/NHWK/8-k
- RSS and alerts for NHWK: https://www.quantisnow.com/docs/rss-feeds.md